New research has FINALLY come out that puts to rest all of the silly myths about the supposed health benefits of water that have turned legions of Americans into water-bottle toting hydration zealots.
Archives for April 2008
Terrorists entering from the North?
According to a new Homeland Security report, the 4,000-mile largely unguarded border with Canada may pose the biggest threat to U.S. security.
The FDA's hit parade of big "oops" stories
The FDA has all the usual flaws that go hand-in-hand with any government bureaucracy. The difference is that when the FDA fouls up, people die.
Reduce your risk of bladder cancer by over 50 percent
A new study revealed that a concentrated extract from broccoli sprouts may reduce the development of bladder cancer by over 50 percent.
Red-light cameras do more harm than good
Researchers in Florida have found that those Orwellian red-light cameras have significantly increased traffic accidents at the intersections where they've been placed.
Is cash greasing the wheels of FDA approvals?
Researchers at Harvard detected a disturbing correlation between the drugs that received lightning-fast FDA approvals and the drugs that ultimately needed to be pulled off the market due to safety issues.
Death toll rises from antibiotic-resistant bacteria
According to the CDC, the strain of common staph bacteria called MRSA (Methicillin-resistant Staphylococcus aureus) is now responsible for more deaths throughout the U.S. than the AIDS virus.
Big shock: People are more likely to get prescriptions when they're cheaper
Socialized medicine will merely make health care in this country less competitive and create a run on drugs and medical care that people often will not need.
Why you should put off prostate treatment
A new study has found that men with early-stage prostate cancer actually aren't at a big risk if they choose to take a wait-and-see approach to treatment rather than going immediately under the knife.
Big Pharma cuts deals to keep profits high
Pharmaceutical companies regularly conspire with their competitors to keep lower-cost generic drugs off the market-a practice that the federal court system seems to wholeheartedly support.

